Publications

Browse our publications catalogue to learn about our research.

Complete molecular remission induced by concomitant cladribine-rituximab treatment in a case of multi-resistant hairy cell leukemia

Francesco Forconi, Francesca Toraldo, Elisa Sozzi, Teresa Amato, Donatella Raspadori & Francesco Lauria, 2007, Leukemia and Lymphoma, 48(12), 2441-2443

DOI: 10.1080/10428190701647903

Type: article

The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia

Monica Else, Nnenna Osuji, Francesco Forconi, Claire Dearden, Ilaria Del Giudice, Estella Matutes, Andrew Wotherspoon, Francesco Lauria & Daniel Catovsky, 2007, Cancer, 110(10), 2240-2247

DOI: 10.1002/cncr.23032

Type: article

Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study

Riccardo Bomben, Michele Dal Bo, Daniela Capello, Dania Benedetti, Daniela Marconi, Antonella Zucchetto, Francesco Forconi, Rossana Maffei, Emanuela M Ghia, Luca Laurenti, Pietro Bulian, Maria Ilaria Del Principe, Giuseppe Palermo, Mia Thorsélius, Massimo Degan, Renato Campanini, Anna Guarini, Giovanni Del Poeta, Richard Rosenquist, Dimitar G Efremov, Roberto Marasca, Robin Foà, Gianluca Gaidano & Valter Gattei, 2007, Blood, 109(7), 2989-2998

DOI: 10.1182/blood-2006-10-051110

Type: article

Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients

Maria Teresa Pirrotta, Monica Bocchia, Alessandro Bucalossi, Marzia Defina, Francesco Forconi, Alessandro Gozzetti & Francesco Lauria, 2007, Acta Haematologica, 118(1), 7-9

DOI: 10.1159/000100992

Type: article

Emerging drugs in chronic myelogenous leukaemia

Monica Bocchia, Francesco Forconi & Francesco Lauria, 2006, Expert Opinion on Emerging Drugs, 11(4), 651-664

DOI: 10.1517/14728214.11.4.651

Type: article

Overlapping morphologic and immunophenotypic profiles in small B-cell lymphoma. A report of two cases

Ioannis Kostopoulos, Mario Cocco, Chiara Ginanneschi, Alessandro D'Amuri, Stefano Lazzi, Alberto Fabbri, Francesco Forconi, Maria Margherita De Santi & Lorenzo Leoncini, 2006, Virchows Archiv, 449(3), 320-327

DOI: 10.1007/s00428-006-0242-1

Type: article

Letter. Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia

M. Bocchia, E. Abruzzese, F. Forconi, M. Ippoliti, M.M. Trawinska, M.T. Pirrotta, D. Raspadori, M. Tozzi, A. Gozzetti & F. Lauria, 2006, Leukemia, 20(1), 142-143

DOI: 10.1038/sj.leu.2404029

Type: article